Overview and Scope
Epinephrine, also known as adrenaline, is a hormone and neurotransmitter used for life-threatening allergic reaction treatment spurred by foods, medicines, latex, insect bites or stings, and other reactions treated with epinephrine injections along with emergency medical treatment.
Sizing and Forecast
The epinephrine market size has grown rapidly in recent years. It will grow from $2.44 billion in 2023 to $2.69 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to anaphylaxis incidence, regulatory framework, increased allergies, patient education, improved accessibility..
The epinephrine market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising allergy rates, expanded access initiatives, awareness campaigns, emerging markets, customized epinephrine delivery systems.. Major trends in the forecast period include integration of smart devices, enhanced education and awareness programs, global expansion of epinephrine access, regulatory emphasis on product safety, collaborations for research and development..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report
Segmentation & Regional Insights
The epinephrine market covered in this report is segmented –
1) By Type: Prefilled Syringe, Auto-injector, Ampoules and Vials
2) By Application: Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
North America was the largest region in the epinephrine market in 2023. The regions covered in the epinephrine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9967&type=smp
Major Driver Impacting Market Growth
The increase in the prevalence of chronic respiratory diseases is expected to propel the growth of the epinephrine market going forward. Chronic respiratory diseases refer to medical condition that affects the lungs and airways of the human body’s respiratory system and has the potential to contract an infection or develop a disease, which can lead to a number of complications. Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis are increasing due to the prevalence of air pollution and harmful environmental, occupational, and behavioral inhalation exposures. Epinephrine is a key medication used in the treatment of severe asthma attacks and anaphylactic reactions, which can cause respiratory distress and potentially life-threatening complications. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . As the prevalence of chronic respiratory diseases continues to increase, the demand for epinephrine is also expected to grow.
Key Industry Players
Major companies operating in epinephrine market are developing innovative products such as OX640 to gain a competitive edge in the market. OX640 is designed to provide a needle-free, user-friendly, and effective treatment for acute allergic reactions, including anaphylaxis, in both community and healthcare settings. For instance, in August 2023, Orexo AB, a Sweden-based pharmaceutical company unveiled that the United States Patent and Trademark Office (USPTO) has granted the first US patent specifically related to OX640, Orexo’s nasal epinephrine powder product based on the amorphous drug delivery platform, amorphOX. This patent protection in the US for OX640 represents a significant milestone for Orexo, as it recognizes the novelty and inventiveness of the product and its underlying drug delivery technology.
The epinephrine market report table of contents includes:
1. Executive Summary
2. Epinephrine Market Characteristics
3. Epinephrine Market Trends And Strategies
4. Epinephrine Market – Macro Economic Scenario
5. Global Epinephrine Market Size and Growth
….
31. Global Epinephrine Market Competitive Benchmarking
32. Global Epinephrine Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Epinephrine Market
34. Epinephrine Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
